International Forum of Allergy & Rhinology · 2023 · 12 citations · 8 references
Life SciencesImmunologyPharmacotherapyAutoimmunityInflammationPathophysiologyEosinophilic DisordersDupilumab ResponseEosinophil BiomarkersEosinophil CountEosinophil-mediated InflammationEosinophilic Disease TherapyHypereosinophilic Syndrome
KEY POINTS: In a limited subset of patients, dupilumab-induced hypereosinophilia is persistent. Two-month follow-up eosinophil count may predict long-lasting hypereosinophilia.
8
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
W.J. Fokkens, Valerie J. Lund, C. Hopkins et al. · Rhinology Journal · 2020 · 5.5K citations · Full text
Medicine, Otolaryngology, Surgery +16
Claus Bachert, Joseph K. Han, Martin Desrosiers et al. · The Lancet · 2019 · 1.5K citations
Medicine, Immunology, Otolaryngology +10
EPOS2020: A Major Step Forward
Wytske J. Fokkens · Rhinology Journal · 2020 · 1.2K citations · Full text
Medicine, Otolaryngology, Surgery +14
Michael E. Wechsler, Amy D. Klion, Pierluigi Paggiaro et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 229 citations · Full text
Medicine, Immunology, Pharmacology +17
William W. Busse, Jorge Máspero, Klaus F. Rabe et al. · Advances in Therapy · 2018 · 184 citations · Full text
Medicine, Immunology, Pharmacology +14